Primary adult soft tissue sarcomas: analysis of 294 patients

被引:0
作者
Necati Alkis
Sadık Muallaoğlu
Murat Koçer
Ülkü Yalçıntaş Arslan
Ayşe Gök Durnalı
Saadet Tokluoğlu
Gökhan Çelenkoğlu
Fatma Paksoy
Ugur Coskun
机构
[1] Ankara Oncology Hospital,Department of Medical Oncology
[2] Ankara Bayındır Hospital,Department of Medical Oncology
[3] Isparta Süleyman Demirel University,Department of Medical Oncology
[4] Gazi University Medical School,Department of Medical Oncology
来源
Medical Oncology | 2011年 / 28卷
关键词
Sarcoma; Adult; Chemotherapy; Radiotherapy;
D O I
暂无
中图分类号
学科分类号
摘要
We retrospectively analyzed 294 patients with primary soft tissue sarcoma followed between 1996 and 2002 in Ankara Oncology Hospital. There were 170 male and 124 female patients with the age range of 16–80 years. The primary tumor was in the extremity in 72.9% of the patients. We determined lung metastasis in 102 (85%) out of the 120 patients as distant metastasis. The most common adult sarcomas were liposarcoma (16.3%), malignant mesenchymal tumor (MMT) (13.9%), malignant fibrous histiocytoma (MFH) (11.2%), rhabdomyosarcoma (10.2%) and synovial sarcoma (10.2%). Seventeen patients (5.3%) had grade 1 tumor, 143 patients (52.2%) had grade 2 tumor, and 112 patients (41.4%) had grade 3 tumor. In 45 patients (15.3%), the grade of the tumors is unknown. The tumor size was 0 to <5 cm in 54 cases (19.4%), 5–10 cm in 117 cases (41.9%) and >10 cm in 108 cases (38.7%). In 15 cases (5.1%), tumor size was unknown. Ninety-five patients (32.4%) were treated with adjuvant chemotherapy, and 125 patients (42.7%)) were treated with palliative chemotherapy. Prognostic factors influencing the overall survival were tumor size, grade, adjuvant radiotherapy and chemotherapy. Adjuvant radiotherapy had influence on disease-free survival. While tumor grade and size showed a significant value for predicting local recurrence, grade, localization of tumor, adjuvant chemotherapy and radiotherapy had an impact on metastasis development. The 1-year overall survival for all patients was 73.4%, 3-year overall survival was 51.8%, and 5-year overall survival was 45.1%.
引用
收藏
页码:391 / 396
页数:5
相关论文
共 102 条
[1]  
Alkış N(2006)Epidemiologic properties of patients who had admitted to Ankara oncology hospital department of medical oncology Ann Oncol 17 abst: 830-877
[2]  
Utkan G(1996)Prognostic factors in adult patients with locally controlled soft tissue sarcoma. A study of 546 patients from the French federation of cancer centers sarcoma group JCO 14 869-1924
[3]  
Durnalı AG(2001)Predictive value of grade for metastasis development in the main histologic types of adult soft tissue sarcomas: a study of 1,240 patients from the French federation of cancer centers sarcoma group Cancer 91 1914-541
[4]  
Arslan ÜY(1984)The grading of soft tissue sarcomas: results of a clinicopathological correlation in a series of 163 cases Cancer 53 530-362
[5]  
Çelenkoğlu G(1997)Comparative study of the national cancer institute and French federation of cancer centers sarcoma group grading systems in a population of 410 adult patients with soft tissue sarcoma JCO 15 350-1684
[6]  
Tokluoğlu S(1996)Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremities JCO 14 1679-44
[7]  
Koçer M(2002)The role of pulmonary metastasectomy in soft tissue sarcoma Semin Thorac Cardiovasc Surg 14 35-558
[8]  
Muallaoğlu S(1986)A randomized trial for the treatment of high-grade soft-tissue sarcomas of the extremities: preliminary observations JCO 4 552-1149
[9]  
Coindre JM(1994)Adjuvant CYVADIC chemotherapy for adult soft tissue sarcoma—reduced local recurrence but no improvement in survival: a study of the European organization for research and treatment of cancer soft tissue and bone sarcoma group JCO 12 1137-1247
[10]  
Terrier P(2001)Adjuvant chemotherapy for adult soft tissue sarcomas of the extremities and girdles: results of the Italian randomized cooperative trial JCO 19 1238-668